The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Gromova D.O.

Sechenov First Moscow State Medical University, Moscow, Russia

Tarapovskaya A.V.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

Chronic cerebral circulatory insufficiency: A clinical case report

Authors:

Gromova D.O., Tarapovskaya A.V.

More about the authors

Journal: Therapeutic Archive. 2016;88(4): 93‑99

Read: 17371 times


To cite this article:

Gromova DO, Tarapovskaya AV. Chronic cerebral circulatory insufficiency: A clinical case report. Therapeutic Archive. 2016;88(4):93‑99. (In Russ.)
https://doi.org/10.17116/terarkh201688493-99

Recommended articles:
Modern aspe­cts of chro­nic cere­bral ischemia pathogenetic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):106-113
Treatment features of patients with vascular cognitive impairments. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):69-76
Prevalence and characteristics of risk factors for cere­brovascular disease in overweight. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):118-124
Radon therapy and high-intensity magnetic therapy in spa treatment of chro­nic dyscirculatory ence­phalopathy. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2025;(3):22-28

References:

  1. Martynov A, Shmyrev V, Ostroumova O, Popova S, Bobrova T. Features white matter lesions of the brain in elderly patients with hypertension. Klinicheskaya meditsina. 2000;6:11-15. (In Russ.)
  2. Pantoni L, Garsia J. Pathogenesis of leukoaraiosis. Stroke. 1997;28:652-659.  doi:10.1161/01.STR.28.3.652
  3. Zheltishchev R, Kamchatnov P, Mikhailova N, Ivashchenko R. The clinical significance of asymptomatic heart attacks in cerebrovascular diseases and their association with cognitive impairment. Nevrologicheskii vestnik. Zhurnal im. V.M. Bekhtereva. 2014;XLVI(2):8-12. (In Russ.)
  4. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Salman R Al-S, Warach S, Launer LJ, Buchem MAV, Breteler MMB. Cerebral microbleeds: a field guide to the detection and interpretation. Lancet Neurology. 2009;8(2):1654-1674. doi:10.1016/S1474-4422(09)70013-4.
  5. Basile AM, Pantoni L, Pracucci G, Asplund K, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M, Brien JO, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitari D. Age, hypertension and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (Leukoaraiosis and disability in the elderly) study. Cerebrovasc Dis. 2006;21(5-6):315-322.  doi:10.1159/000091536.
  6. Yakhno N, Levin O, Damulin I. Comparison of clinical and MRT data vascular encephalopathy. Message 1: movement disorders. Nevrologicheskii zhurnal. 2001;6(2):10-16. (In Russ.)
  7. Yakhno N, Levin O, Damulin I. Comparison of clinical and MRT data vascular encephalopathy. Message 2: cognitive impairment. Nevrologicheskii zhurnal. 2001;6(3):10-19. (In Russ.)
  8. Zhetishev R, Kamchatnov P, Mikhailova N, Ivashchenko A. Prevalence and risk factors of asymptomatic cerebral infarction. Klinitsist. 2015;9(1):13-17. (In Russ.) doi:10.17650/1818-8338-2015-1-13-17.
  9. Preobrazhenskaya I, Yakhno N. Vascular cognitive impairment: clinical manifestations, diagnosis, treatment. Nevrologicheskii zhurnal. 2007;12(5):45-50. (In Russ.)
  10. Zakharov V, Vakhnina N. Diagnosis and treatment of vascular cognitive impairments. Consilium Medicum. Neurology and Rheumatology (Suppl.) 2015;1:5-10. (In Russ.)
  11. Zakharov V, Gromova D. Diagnostics and Treatment of Chronic Cerebrovascular Insuiciency. Effektivnaya farmakoterapiya. Nevrologiya i psikhiatriya. 2015;2:48-54. (In Russ.)
  12. Alexpoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. Vascular depression hypothesis. Arch Gen Psychiatry. 1997;54:915-922.  doi:10.1001/archpsyc.1997.01830220033006.
  13. Krishnan KRR, Hays JC, Blazer DG. MRI-defined vascular depression. Am J Psychiatry. 1997;154:497-501.  doi:10.1176/ajp.154.4.497.
  14. Hama S, Yamashita H, Shigenobu M, Watanabe A, Kurisu K, Yamawaki S, Kitaoka T. Post-stroke affective or apathetic depression and lesion location: left frontal lobe and bilateral basal ganglia. Eur Arch Psych Clin Neurosci. 2007;257:149-152.
  15. Teodorczuk A, Firbank MG, Pantoni L et al. Relationship between late-life white matter changes and development of late life depressive symptoms: 3 years results from the LADIS study. Psychol Med. 2010;40(4):603-610.
  16. Firbank MJ, Teodorczuk A, van der Filler M, Gouw AA, Wallin A., Erkinjuntti T, Inzitari D, Wahlund L-O, Pantoni L, Poggesi A, Pracucci G, Langhorne P, O’Brien J, the LADIS group. Relationship between progression of brain white matter changes and late life depressive symptoms: 3 years results from the LADIS study. Br J Psychiatr. 2012;201(1):40-45.
  17. Sneed JR, Culang-Reinlieb ME. The vascular depression hypothesis: an update. Am J Ger Psychiatry. 2011;19(2):99-103.  doi:10.1097/JGP.0b013e318202fc8a.
  18. Yakhno N, Zakharov V, Lokshina A. The syndrome of mild cognitive disorders in discirculatory encephalopathy. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2005;105(2):13-17. (In Russ.)
  19. Yakhno N, Lokshina A, Zakharov V. Light and mild cognitive disorders in discirculatory encephalopathy. Nevrologicheskii zhurnal. 2004;2:30-35. (In Russ.)
  20. Yakhno N. Cognitive impairment in neurological clinic. Nevrologicheskii zhurnal. 2006;11(Prilozhenie 1):4-12. (In Russ.)
  21. Shvareva I, Alekseev V, Yakhno N. Headaches with hypertension. Biomeditsinskie tekhnologii i radioelektronika. 2002;8:4-10. (In Russ.)
  22. Alekseev V, Shvareva I, Parfenov V, Ryzhak A. Headache in patients with arterial hypertension. Klinicheskaya gerontologiya. 2001;5:3-9. (In Russ.)
  23. Yakhno N, Parfenov V, Alekseev V. Headache. Mоscow: Remedium; 2000:51. (In Russ.)
  24. Classification and diagnostic criteria for headache disorder, cranial neuralgias and facial pain.Headache classification committee of the international headache society. Cephalalgia. 1988;8(Suppl. 7):96.
  25. Levin Ya, Poluektov M. Somnology and sleep Medicine. Moscow; 2013. (In Russ.)
  26. Lyang O, Kochetov A. The use of mexidol in chronic cerebral ischemia. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2013;12:126-129. (In Russ.)
  27. Abramenko Yu. The assessment of the clinical efficacy, vasoactive and metabolic effects of mexidol in elderly patients with discirculatory encephalopathy. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2011;11:35-41. (In Russ.)
  28. Smirnova I, Fedorova T, Tanashyan M, Suslina Z. Clinical efficacy and antioxidant activity mexidol in chronic cerebrovascular diseases. Nervnye bolezni. 2006;1:33-36. (In Russ.)
  29. Tanyashyan M, Lagoda O, Antonova S. Chronic cerebrovascular diseases associated with metabolic syndrome: new treatment approaches Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2012;112(11):21-26. (In Russ.)
  30. Chukanova E, Chukanova A, Mamaeva Kh. The results of the study of the efficacy and safety of mexidol in patients with chronic cerebral ischemia. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2015;2:71-74. (In Russ.)
  31. Drozdova T, Fit'mova O, Fit'mova A. Mexidol role in the treatment of mild cognitive impairment in chronic cerebrovascular insufficiency. Farmateka. 2012;14:97-103. (In Russ.)
  32. Rubina S. Efficiency mexidol in the treatment of cognitive impairment in elderly patients with dyscirculatory encephalopathy. Byulleten' eksperimental'noi biologii i meditsiny. 2012;Prilozhenie 1:46-31. (In Russ.)
  33. Shetakauri S. Modern possibilities of antioxidant therapy and experience of treatment patients with meksidolom chronic cerebrovascular insufficiency. Byulleten' eksperimental'noi biologii i meditsiny. 2006. Prilozhenie 1:156-158. (In Russ.)
  34. Duma S. Possibilities of antioxidant therapy for asthenia and cognitive deficit in elderly patients with chronic brain ischemia. Terapevticheskii arkhiv. 2013;12:100-105. (In Russ.)
  35. Antipenko E. Adaptogenic effects of mexidol in chronic cerebral ischemia. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2012;3:49-54. (In Russ.)

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.